Johns Hopkins study of through-the-nipple breast cancer therapy shows promise in early tests:

Johns Hopkins study of through-the-nipple breast cancer therapy shows promise in early tests:   NCI Cancer Center News Delivering anticancer drugs into breast ducts via the nipple is highly effective in animal models of early breast cancer, and has no major side effects in human patients, according to a report by Johns Hopkins Kimmel Cancer … Continue reading “Johns Hopkins study of through-the-nipple breast cancer therapy shows promise in early tests:”

Johns Hopkins study of through-the-nipple breast cancer therapy shows promise in early tests:

 

NCI Cancer Center News

Delivering anticancer drugs into breast ducts via the nipple is highly effective in animal models of early breast cancer, and has no major side effects in human patients, according to a report by Johns Hopkins Kimmel Cancer Center researchers in Science Translational Medicine on Oct. 26. The results of the study are expected to lead to more advanced clinical trials of so-called intraductal treatment for early breast cancer.

Click here to read full press release from Johns Hopkins.

###

Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

Author: Joe Lovrek

Born in Houston, Raised in Trinity Texas

Leave a Reply